Business Description
Sinew Pharma Inc
ISIN : TW0006634009
Description
Sinew Pharma Inc is a Taiwan-based biopharmaceutical company. The company is mainly engaged in the research and development of new drugs for the treatment of liver diseases and pain relief. Its drug candidates includes SNP-610, SNP-630, SNP-810, SNP-820, SNP-830 and SNP-840.
Financial Strength
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 198.67 | |||||
| Equity-to-Asset | 0.98 | |||||
| Debt-to-Equity | 0.01 | |||||
| Debt-to-EBITDA | -0.1 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | 69.08 | |||||
| Beneish M-Score | 40.52 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | -4.8 | |||||
| 3-Year EPS without NRI Growth Rate | -1.5 | |||||
| 3-Year FCF Growth Rate | 4.7 | |||||
| 3-Year Book Growth Rate | 69.7 |
Momentum Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 51.96 | |||||
| 9-Day RSI | 42.73 | |||||
| 14-Day RSI | 38.62 | |||||
| 6-1 Month Momentum % | -23.78 | |||||
| 12-1 Month Momentum % | -26.79 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 44.44 | |||||
| Quick Ratio | 44.44 | |||||
| Cash Ratio | 43.58 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -20.9 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 88.41 | |||||
| Operating Margin % | -45252.44 | |||||
| Net Margin % | -42737.8 | |||||
| FCF Margin % | -18251.22 | |||||
| ROE % | -5.53 | |||||
| ROA % | -5.41 | |||||
| ROIC % | -112.05 | |||||
| ROC (Joel Greenblatt) % | -407.02 | |||||
| ROCE % | -5.49 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 9430 | |||||
| PB Ratio | 2.67 | |||||
| Price-to-Tangible-Book | 2.73 | |||||
| EV-to-EBIT | -29.3 | |||||
| EV-to-EBITDA | -36.91 | |||||
| EV-to-Revenue | 6575.74 | |||||
| EV-to-FCF | -34.42 | |||||
| Price-to-Projected-FCF | 5.99 | |||||
| Price-to-Net-Current-Asset-Value | 2.79 | |||||
| Price-to-Net-Cash | 2.84 | |||||
| Earnings Yield (Greenblatt) % | -3.41 | |||||
| FCF Yield % | -1.78 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Sinew Pharma Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil NT$) | 0.328 | ||
| EPS (TTM) (NT$) | -1.04 | ||
| Beta | -0.12 | ||
| Volatility % | 39.07 | ||
| 14-Day RSI | 38.62 | ||
| 14-Day ATR (NT$) | 1.597198 | ||
| 20-Day SMA (NT$) | 48.345 | ||
| 12-1 Month Momentum % | -26.79 | ||
| 52-Week Range (NT$) | 43.85 - 80.9 | ||
| Shares Outstanding (Mil) | 71.33 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Sinew Pharma Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Sinew Pharma Inc Stock Events
| Event | Date | Price(NT$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Sinew Pharma Inc Frequently Asked Questions
What is Sinew Pharma Inc(ROCO:6634)'s stock price today?
The current price of ROCO:6634 is NT$47.15. The 52 week high of ROCO:6634 is NT$80.90 and 52 week low is NT$43.85.
When is next earnings date of Sinew Pharma Inc(ROCO:6634)?
The next earnings date of Sinew Pharma Inc(ROCO:6634) is .
Does Sinew Pharma Inc(ROCO:6634) pay dividends? If so, how much?
Sinew Pharma Inc(ROCO:6634) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers